AlphAIAlphAI — Financial news for AI agents
marketscreener.comSEP 161 min read$A

Agilent Technologies Keeps Quarterly Dividend at $0.255 per Share

Agilent Technologies maintained its quarterly dividend at $0.255 per share. The company's stock has seen a 5-day change of 2.28%, a 1st Jan change of 4.66%, and a 12.95% increase overall. This follows a recent downgrade by UBS.

Original reporting
marketscreener.com
Published Sep 16, 2026, 9:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 9:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefCorporate actions
Primary signal
$A
Neutral
high confidence
Mentioned
$A
Relevance
4/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$ANeutralLow
01

Why it matters

The announcement provides no new upside, keeping the stock's valuation unchanged.

02

Market read

A routine dividend maintenance announcement with minimal trading relevance.

03

What to watch

Potential upcoming earnings could alter dividend policy; watch next quarter.

Relevance 4/10Novelty 2/10Timing: post-market announcement

Background

Agilent Technologies (ticker A) regularly announces quarterly dividends; the current level remains $0.255.

Company-level read

Ticker impact

$ANeutralHigh confidence
Context

Agilent announced it will keep its quarterly dividend at $0.255 per share.

Expected impact

minimal, likely flat to slight dip as no new yield increase.

Evidence & confidence

Investors already price in the existing dividend; no change means no catalyst.

Market effects

Sector

None; dividend policy unchanged for the life sciences instrumentation sector.

Regional

No regional effect.

Global

Limited to Agilent shareholders.

Counterpoint

What could challenge this read

If investors seek yield, the unchanged dividend may signal limited growth, prompting a sell.

Key entities

  • Company
    Agilent Technologies

    US-listed life‑sciences instrumentation and diagnostics company.

Read at source← All news

Related articles

SEP 7
$AMed

Agilent (A) Upgraded to Buy: What Does It Mean for the Stock?

Agilent Technologies (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting an upward trend in earnings estimates. The Zacks rating system, which is based on earnings estimate revisions, suggests a positive outlook for the company's stock price. Analysts have raised their estimates for Agilent by 3.4% over the past three months, with the company expected to earn $6.17 per share for the fiscal year ending October 2026.

finance.yahoo.com2 min
AUG 31
$AHighAI 8/10

Agilent (A) Q3 2026 Earnings Call Transcript

Agilent (A) reported Q3 2026 revenue of $1.88B, up 7.3% and exceeding guidance. EPS was $1.56, up 14% YoY. Strong performance driven by pharma, China growth, and Ignite strategy. Key growth areas include pharma, semiconductors, and AI infrastructure.

yahoo.com2 min
AUG 29
$AHighAI 8/10

Stronger Q3 Results and Raised Guidance Could Be A Game Changer For Agilent Technologies (A)

Agilent Technologies (A) reported Q3 2026 sales of $1.88B and net income of $362M, with EPS rising to $1.28. The company raised its full-year revenue and profit guidance, citing strong demand in pharma, China, and advanced materials, plus cost savings from its Ignite program. The updated outlook suggests margin benefits and product launches are offsetting cost pressures. Investors should note ongoing tariff and supply chain risks. Analysts' fair value estimates for Agilent range from $150.54 to

simplywall.st3 min
AUG 27
$AHighAI 8/10

Agilent earnings analysis: questions answered and next catalysts

Agilent reported FY2026 Q3 earnings with EPS of $1.62 (8.7% above consensus) and revenue of $1.88B (2.2% above estimates). This marks the third consecutive quarter of EPS acceleration, with revenue growth of 6.7% in FY2025. However, gross margins slipped to 52.4% and free cash flow declined to $1.15B. The stock trades at 30.9x trailing P/E, with a fair-value estimate of $145.64, suggesting a 7.6% overvaluation.

investing.com2 min